World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 15 July 2019
Main ID:  ACTRN12618000521224
Date of registration: 09/04/2018
Prospective Registration: Yes
Primary sponsor: Basak ALTIPARMAK
Public title: Comparison of the effect of Preoperative Pregabalin and Duloxetine on Postoperative Pain and Cognitive Function After Spinal Surgery
Scientific title: Comparison of Preoperative Pregabalin and Duloxetine on Postoperative Pain and Cognitive Function of Adult Patients Undergoing Spinal Surgery
Date of first enrolment: 22/04/2018
Target sample size: 90
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12618000521224.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Safety/efficacy;  
Phase:  Phase 4
Countries of recruitment
Turkey
Contacts
Name: Dr Basak ALTIPARMAK   
Address:  Mugla Sitki Koçman Üniversitesi Tip Fakültesi. Marmaris yolu üzeri M kapi karsisi. 48000 (postcode) Mentese/MUGLA Turkey
Telephone: +905326726533
Email: basakugurlu@me.com
Affiliation: 
Name: Dr Basak ALTIPARMAK   
Address:  Mugla Sitki Koçman Üniversitesi Tip Fakültesi. Marmaris yolu üzeri M kapi karsisi. 48000 (postcode) Mentese/MUGLA Turkey
Telephone: +905326726533
Email: basakugurlu@me.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Age between 18-65, ASA I, II and III, patients with lumbar disc herniation
Exclusion criteria: Known allergy for study drugs, impaired hepatic and/or renal function, history of chronic use of analgesics, alcohol and drug abuse, morbidly obese patients, patients with a preoperative Montreal cognitive assessment evaluation score under 24

Age minimum: 18 Years
Age maximum: 65 Years
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Anaesthesiology - Pain management
Postoperative pain after elective decompression laminectomy for lumbar disc herniation ;Cognitive function after elective laminectomy for lumbar disc herniation ;
Postoperative pain after elective decompression laminectomy for lumbar disc herniation
Cognitive function after elective laminectomy for lumbar disc herniation
Mental Health - Studies of normal psychology, cognitive function and behaviour
Intervention(s)
The adult patients scheduled for elective repair of lumbar disc herniation will randomly be divided into three groups. The randomization will be based on a computerized randomization table created by a researcher who will not involve in the study. The patients assigned in the first group will orally receive 75 mg pregabalin one hour before the operation. The dose (75 mg) will be repeated orally at the postoperative 12th and 24th hour, The patients in the second group will orally receive 60 mg duloxetine one hour before the operation. At the postoperative 12th hour, the patients in the second group will receive a matched-place capsule and at the 24th hour, they will orally receive 60 mg duloxetine again. The patients in the third group will orally receive matching placebo capsules at all time-points. One of the researchers who will be blind to the study groups and study drugs will directly observe the patients while receiving the capsules. At the end of the operation, 1 mg/kg intravenous tramadol will be applied to all of the patients for postoperative pain control. All of the patients will be assessed with Montreal Cognitive Assessment evaluations for cognitive function evaluation at the day before the operation and six hours after the operation. Postoperative pain evaluation will be done according to visual analog scale by a researcher who will be blinded to the study groups at the postoperative first minute, 30. minute, first hour, 12. hour, 24. and 48 hour.
Primary Outcome(s)
.To compare the reduction in postoperative first hour pain scores as assessed by 100mm visual analogue scale after preoperative administration of pregabalin 75 mg and duloxetine 60 mg [At postoperative first minute, 30th minute, first hour (primary timepoint), second hour, 12th hour, 24th hour and 48th hour ]
To compare the effect of preoperatively administered pregabalin 75 mg and duloxetine 60 mg on postoperative cognitive functions as assessed by 30 point Montreal Cognitive Assessment Test [At the postoperative 6th hour ]
.To compare the reduction in postoperative 48th hour pain scores as assessed by 100mm visual analogue scale after preoperative administration of pregabalin 75 mg and duloxetine 60 mg [At the postoperative 48th hour ]
Secondary Outcome(s)
To determine the side-effects such as nausea, vomiting and dizziness by directly asking the patient at different timepoints, or hypotension and hypertension by analyzing the nurse-care records at the ward [At the postoperative first minute, 6th, 12th, 24th and 48th hour ]
Secondary ID(s)
Nil Known
Source(s) of Monetary Support
Hacettepe University Hospital
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Mugla Sitki Koçman University Training and Research Hospital Institutional Ethics Committee
Results
Results available: Yes
Date Posted: 05/06/2019
Date Completed: 19/05/2018
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history